Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InvesqueSourcebio InternationalNMC HealthAsian American Medical GroupCareRx
Price Information
Current PriceC$3.75GBX 193.75$0.39N/A$4.27
52 Week RangeHoldBuyN/AN/ABuy
Overall Score0.
Analysis Score1.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationHoldN/AN/AN/ABuy
Consensus Price TargetC$2.50GBX 230N/AN/A$7.00
% Upside from Price Target-33.33% downside18.71% upsideN/AN/A63.93% upside
Trade Information
Market CapC$209.54 million£137.24 million$81.40 millionN/AN/A
Average Volume29,654156,027476,966N/A2,247
Sales & Book Value
Annual RevenueC$207.96 millionN/A$2.06 billion$7.21 millionN/A
Price / Sales1.01N/A0.040.00N/A
CashflowC$0.29 per shareN/AN/AN/AN/A
Price / Cash13.02N/AN/AN/AN/A
Book ValueC$3.72 per shareN/AN/AA$0.03 per shareN/A
Price / Book1.01N/A0.00N/A
Net IncomeN/AN/AN/AN/AN/A
Trailing P/E RatioN/A0.
Forward P/E RatioN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio385.95%N/AN/A16.77%N/A
Current Ratio0.96%N/AN/A1.39%N/A
Quick Ratio0.79%N/AN/A0.75%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding55.88 million74.18 million208.70 million347.75 millionN/A
Next Earnings Date5/12/2021 (Estimated)N/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
CareRx (OTCMKTS:CHHHF)  Shares Down 3.4% CareRx (OTCMKTS:CHHHF) Shares Down 3.4% - April 6 at 12:54 AM
Could The CareRx Corporation (TSE:CRRX) Ownership Structure Tell Us Something Useful?Could The CareRx Corporation (TSE:CRRX) Ownership Structure Tell Us Something Useful? - April 2 at 1:30 PM
CareRx Completes Acquistion of SmartMeds PharmacyCareRx Completes Acquistion of SmartMeds Pharmacy - April 1 at 9:26 AM
3/15/2021InvesqueNational Bank FinancialReiterated Rating
3/12/2021InvesqueCanaccord GenuityBoost Price Target
6/29/2020InvesqueEchelon Wealth PartnersReiterated Rating
4/13/2021Sourcebio InternationalLiberum CapitalReiterated Rating
11/27/2018NMC HealthJefferies Financial GroupDowngrade
11/21/2018NMC HealthJPMorgan Chase & Co.Upgrade
2/4/2021CareRxDesjardinsInitiated Coverage
6/29/2020CareRxStifel NicolausInitiated Coverage
(Data available from 4/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.